Table 3.
Referral diagnosis | Final Diagnosis | n |
---|---|---|
Benign | Malignant (Including locally aggressive, although non-metastasising neoplasms) | |
| ||
Angiomyxoma | Fibromatosis | 1 |
Nerve sheath tumour | Fibromatosis | 1 |
Granular cell tumour (benign) | Granular cell tumour (malignant) | 4 (1 patient) |
Haemangiopericytoma | DDL | 1 |
Leiomyoma | Leiomyosarcoma | 2 |
Reactive tissue | Leiomyosarcoma | 1 |
| ||
Malignant (Including locally aggressive although non-metastasising neoplasms) | Benign | |
| ||
Fibromatosis | Scar | 1 |
Fibromatosis | Nuchal-type fibroma | 1 |
ALT | Lipoma | 2 |
MPNST | Atypical neurofibroma | 1 |
Leiomyosarcoma | BFH | 1 |
DFSP | BFH | 1 |
Metastatic renal carcinoma | Clear cell BFH | 1 |
Angiosarcoma | Haemangioma | 1 |
GIST | Fibrous tissue only | 1 |
Leiomyosarcoma | Schwannoma | 1 |
IMT | Wegener's granulomatosis | 1 |
| ||
Malignant | Malignant | |
| ||
STUMP | Leiomyosarcoma (grade 2) | 2 |
ESS | Leiomyosarcoma | 1 |
ESS | Osteosarcoma | 1 |
GIST | Spindle cell sarcoma | 1 |
GIST | Spindle RMS | 1 |
Leiomyosarcoma | MPNST | 1 |
LGFMS | Fibromatosis | 1 |
LGFMS | DDL | 1 |
Synovial sarcoma | Malignant neoplasm | 1 |
| ||
Benign | Benign | |
| ||
Schwannoma | Benign naevus | 1 |
| ||
Mesenchymal | Non-mesenchymal | |
| ||
UPS | Carcinosarcoma | 4 |
Synovial sarcoma | Carcinosarcoma | 1 |
Chondrosarcoma | Carcinosarcoma | 1 |
Leiomyosarcoma | Carcinosarcoma | 1 |
Sarcoma | Seminoma | 1 |
MPNST | Melanoma | 2 |
Non-mesenchymal | Mesenchymal | |
| ||
Carcinoma | Pleomorphic RMS | 1 |
Carcinoma | Spindle cell sarcoma | 1 |
Lymphoma | SFT | 1 |
| ||
Non-mesenchymal | Non-mesenchymal | |
| ||
Undifferentiated carcinoma | Prostatic carcinoma | 1 |
| ||
Grade | Grade | |
| ||
GIST grade 2/3 | GIST 1 | 2 |
Leiomyosarcoma 2/3 | Leiomyosarcoma 1 | 2 |
Leiomyosarcoma 1 | Leiomyosarcoma 2 | 1 |
Myxofibrosarcoma 2 | Myxofibrosarcoma 1 | 1 |
WDL | DDL grade 2 | 1 |
High grade sarcoma | ESS | 1 |
Abbreviations: ALT atypical lipomatous tumour; BFH benign fibrous histiocytoma; DFSP dermatofibrosarcoma protuberans; DDL dedifferentiated liposarcoma; ESS endometrial stromal sarcoma; GIST gastrointestinal stromal tumour; IMT inflammatory myofibroblastic tumour; LGFMS low grade fibromyxoid sarcoma; MPNST malignant peripheral nerve sheath tumour; RMS rhabdomyosarcoma; SFT solitary fibrous tumour; STUMP smooth muscle tumour of uncertain malignant potential; UPS undifferentiated pleomorphic sarcoma; WDL well differentiated liposarcoma.